| 1 |
33197900 | Application of ZnO/CNT@Fe3O4nanocomposite in amplifying the anti-leukemic effects of Imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia. | 2021 Mar 5 |
2 |
| 2 |
34843676 | Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation. | 2021 Dec 15 |
1 |
| 3 |
32430012 | Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells. | 2020 May 19 |
3 |
| 4 |
30738487 | [Research Progress of C-Myc in Chronic Myelogenous Leukemia --Review]. | 2019 Feb |
2 |
| 5 |
29423056 | Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia. | 2018 Jan 9 |
5 |
| 6 |
30153828 | The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells. | 2018 Aug 28 |
1 |
| 7 |
30687103 | A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells. | 2018 |
1 |
| 8 |
27550925 | Original Research: Featured Article: Imatinib mesylate (Gleevec) inhibits Notch and c-Myc signaling: Five-day treatment permanently rescues mammary development. | 2017 Jan |
1 |
| 9 |
27825294 | Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance. | 2017 May |
2 |
| 10 |
28069548 | Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia. | 2017 Apr 5 |
1 |
| 11 |
27281222 | Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells. | 2016 Jun 16 |
1 |
| 12 |
25647305 | Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis. | 2015 |
1 |
| 13 |
25765543 | Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients. | 2015 Jul |
1 |
| 14 |
26248946 | Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway. | 2015 Oct |
1 |
| 15 |
22710719 | MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.). | 2013 Apr 25 |
8 |
| 16 |
22842456 | Myc induced miR-144/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562. | 2012 Aug 24 |
5 |
| 17 |
21460180 | MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib. | 2011 May |
4 |
| 18 |
20807813 | A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors. | 2010 Sep 15 |
1 |
| 19 |
19602047 | Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy. | 2009 Aug |
1 |
| 20 |
18086564 | Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha. | 2008 Feb 22 |
1 |
| 21 |
18429956 | Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL: in vitro and in vivo studies. | 2008 Jun |
1 |
| 22 |
15517875 | Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. | 2004 Sep-Oct |
1 |
| 23 |
12370803 | Jak2 is involved in c-Myc induction by Bcr-Abl. | 2002 Oct 17 |
1 |